Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Sep 15, 2026
Circle Internet Group (CRCL): A Closer Look at the USDC Issuer

Circle Internet Group (CRCL): A Closer Look at the USDC Issuer

Key Takeaways

  • CRCL is the Class A common stock of Circle Internet Group, Inc., a financial technology company best known as the issuer of USDC, one of the world's largest dollar-backed stablecoins.
  • Circle operates digital-asset infrastructure, including the USDC and EURC stablecoins, a tokenized money market fund (USYC), and blockchain and developer services.
  • The company was founded in 2013, is headquartered in New York, and began trading on the New York Stock Exchange in June 2025.
  • Circle's business model combines interest earned on the reserves backing its stablecoins with fees from payments, developer, and infrastructure services.
  • Investors follow CRCL for its exposure to the growth of stablecoin payments, digital finance, and regulated blockchain infrastructure, alongside meaningful regulatory and competitive risks.

Introduction to Circle Internet Group

Circle Internet Group, Inc. builds payment and market infrastructure for digital currencies and public blockchains. It is most widely recognized as the issuer of USDC, a stablecoin designed to maintain a value of one U.S. dollar per token. Because USDC is used to move money, settle transactions, and power blockchain-based applications around the world, Circle occupies a central position in the emerging digital-asset economy. Investors follow CRCL as a way to gain exposure to that ecosystem through a publicly traded U.S. company.

Circle's Business Model and Operations

A stablecoin is a digital asset engineered to hold a stable value, typically by being pegged to a traditional currency such as the U.S. dollar or the euro. Circle issues two principal stablecoins: USDC, pegged to the U.S. dollar, and EURC, pegged to the euro. The company also offers USYC, a tokenized money market fund, along with related custody, liquidity, and trust services. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Circle's core revenue model is closely tied to the reserves that back its stablecoins. The company holds the dollars customers exchange for USDC in highly liquid assets, primarily short-duration U.S. Treasury securities and cash equivalents, and earns interest on those reserves. In addition, Circle generates revenue from payment services, developer and application programming interface (API) offerings, and blockchain infrastructure used by businesses to build on-chain financial products.

The company organizes its platform around three broad areas. Its blockchain and developer infrastructure includes a layer-1 network designed to bring real-world economic activity on-chain. Its digital-assets and services segment encompasses USDC, EURC, USYC, minting, custody, and trust infrastructure. Its applications segment includes payments and products that use Circle's digital assets to deliver real-world utility across a multichain ecosystem.

History, Leadership, and Market Position

Circle was founded in 2013 by entrepreneur Jeremy Allaire, who serves as co-founder, chairman, and chief executive officer, and is headquartered at One World Trade Center in New York. The company launched USDC in 2018 through a consortium now known as Centre, and it has since grown into one of the largest stablecoin issuers globally, with a leading position in the U.S. market.

After operating privately for more than a decade, Circle went public on June 5, 2025, with its Class A common stock listed on the New York Stock Exchange under the ticker CRCL. The company's financial profile reflects the dual nature of its business: interest income from reserve assets provides a substantial base of earnings, while its payments, developer, and infrastructure offerings aim to capture growth as digital payments and tokenized finance expand.

Circle's competitive positioning rests on several pillars. Its focus on regulatory compliance and transparency has helped it build trust with institutional partners, while its integration across multiple blockchains makes USDC broadly usable. The company competes with other stablecoin issuers, traditional payment processors, and financial institutions, but its scale, distribution, and regulatory standing give it a distinctive role in the sector.

Why Investors Follow CRCL

Investors follow CRCL primarily because it offers regulated, equity-based exposure to the growth of stablecoins and digital payments. Stablecoin usage has expanded as businesses use them for faster, lower-cost cross-border transactions, treasury management, and blockchain-based settlement. As the issuer of USDC, Circle stands to benefit from rising adoption across these use cases. From what I see, the interest income from reserves adds a layer of visibility to its earnings that sets it apart.

Circle also earns attention for its strategic positioning in the broader tokenization trend, in which traditional assets such as money market funds are represented digitally on blockchains. Its USYC product and developer platform position the company to participate as more financial activity moves on-chain. In addition, the interest income generated from USDC reserves gives Circle a financial profile that is distinct from many technology companies, providing a visible revenue base tied to the scale of its stablecoin supply.

Risks and Important Considerations

Investing in CRCL involves several meaningful risks. The company's revenue is sensitive to the size of its stablecoin reserves and to prevailing interest rates, meaning its earnings can fluctuate with changes in monetary policy or in demand for USDC. A decline in stablecoin supply or in interest rates could pressure the income Circle generates from its reserve portfolio.

Regulatory risk is also significant. Stablecoins are the subject of evolving rulemaking in the United States and other jurisdictions, and changes in how stablecoins are supervised, licensed, or taxed could affect Circle's operations and costs. The company also faces intense competition from other stablecoin issuers, payment networks, and large technology and financial firms, and its business depends on the continued adoption, security, and stability of public blockchains and the broader crypto-asset market.

Finally, Circle does not currently pay a dividend, and its shares may experience volatility tied to digital-asset market sentiment, technology developments, and macroeconomic conditions. Investors should consider these factors alongside the company's growth opportunities.

Conclusion

Circle Internet Group is a distinctive company that sits at the intersection of traditional finance and digital assets. As the issuer of USDC, it provides critical infrastructure for a growing stablecoin economy while also expanding into tokenized funds and blockchain-based services. Its regulated approach, established brand, and reserve-driven revenue model distinguish it from many other digital-asset companies, making CRCL a closely watched name for investors seeking exposure to the evolution of digital payments and financial infrastructure.

Using Tickeron’s AI Tools in My Research

In my research process, I often rely on Tickeron’s AI Screener to quickly filter stocks and ETFs by technical indicators, fundamentals, and AI signals. It helps me compare opportunities like CRCL against peers and refine ideas that align with specific strategies, saving time while supporting more informed decisions.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CRCL

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


CRCL's RSI Oscillator recovers from overbought zone

The 10-day RSI Oscillator for CRCL moved out of overbought territory on September 04, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 2 instances where the indicator moved out of the overbought zone. In 2 of the 2 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CRCL as a result. In 25 of 25 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for CRCL turned negative on September 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 6 similar instances when the indicator turned negative. In 5 of the 6 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRCL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

CRCL moved above its 50-day moving average on October 05, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +3.06% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRCL advanced for three days, in 50 of 62 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

CRCL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 21 of 34 cases where CRCL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 55 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. CRCL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.207) is normal, around the industry mean (4.351). P/E Ratio (17.194) is within average values for comparable stocks, (30.023). CRCL's Projected Growth (PEG Ratio) (4.345) is very high in comparison to the industry average of (0.809). Dividend Yield (0.000) settles around the average of (0.016) among similar stocks. P/S Ratio (6.954) is also within normal values, averaging (16.763).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRCL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.

Notable companies

The most notable companies in this group are Morgan Stanley (NYSE:MS), Goldman Sachs Group (NYSE:GS), Charles Schwab Corp (The) (NYSE:SCHW), Gold.com Inc. (NYSE:GOLD).

Industry description

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

Market Cap

The average market capitalization across the Investment Banks/Brokers Industry is 12.69B. The market cap for tickers in the group ranges from 590 to 304.12B. MS holds the highest valuation in this group at 304.12B. The lowest valued company is FSSLD at 590.

High and low price notable news

The average weekly price growth across all stocks in the Investment Banks/Brokers Industry was 0%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was 3%. XP experienced the highest price growth at 39%, while PMAX experienced the biggest fall at -35%.

Volume

The average weekly volume growth across all stocks in the Investment Banks/Brokers Industry was 12%. For the same stocks of the Industry, the average monthly volume growth was -6% and the average quarterly volume growth was -50%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 66
P/E Growth Rating: 63
Price Growth Rating: 59
SMR Rating: 74
Profit Risk Rating: 86
Seasonality Score: 24 (-100 ... +100)
View a ticker or compare two or three
CRCL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry InvestmentBanksBrokers

Industry
N/A
Address
One World Trade Center
Phone
+1 332 334-0660
Employees
1100
Web
https://www.circle.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.
Following the Kenvue consumer health spin-off, Johnson & Johnson has transformed into a focused healthcare leader, emphasizing Innovative Medicine (pharmaceuticals) and MedTech (devices). In my view, this repositioning sharpens the company's edge in high-margin areas such as oncology, immunology, neuroscience, cardiovascular, surgery, and vision, where its diversified portfolio and R&D efficiency provide clear competitive advantages.
I've long appreciated ASML Holding N.V.'s dominant position in the semiconductor lithography market. The company commands over 90% share in advanced deep ultraviolet (DUV) immersion systems and 100% in EUV lithography—the critical technology for chips below 7nm nodes used in AI, high-performance computing, and memory. This near-monopoly comes from decades of R&D investment, exclusive partnerships like Zeiss for optics, and a vast installed base that generates steady service revenue. From what I see, competitors such as Nikon and Canon remain far behind in EUV, sticking to mature nodes.
I've been watching Micron Technology (MU) closely through its recent volatility, which mirrors the semiconductor sector's heightened sensitivity to AI demand and supply constraints. The stock saw a sharp post-earnings sell-off tied to elevated capital expenditure plans, yet it has rebounded with surging DRAM prices—up 90-95%—and memory suppliers booked out for years. From what I see, broader tech optimism, including key partnerships and persistent supply tightness, is driving upward momentum. This positions MU as a pivotal player in high-bandwidth memory (HBM) for data centers. Trading near recent highs around $368, the shares highlight investor focus on Micron's critical role in the AI infrastructure expansion under these constrained industry conditions.